Sona Nanotech Inc.
OTC: SNANF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- David Andrew Regan
- Employees
- 8
- Headquarters
- Halifax, Canada
- IPO year
- 2006
- Market cap
- $25.4M
- Website
- https://www.sonanano.com
Loading SNANF…
Loading profile data…Frequently asked questions about SNANF
What does Sona Nanotech Inc. (SNANF) do?
Sona Nanotech Inc. is a life sciences enterprise specializing in nanotechnology, primarily engaged in the development and commercialization of gold nanorod products for diagnostic purposes. The company's offerings also encompass distinct gold nanorod varieties, such as Gemini and Omni (the latter tailored specifically for medical uses), alongsid...
Where does SNANF trade?
Sona Nanotech Inc. (SNANF) trades on the Other OTC.
What sector is SNANF in?
Sona Nanotech Inc. (SNANF) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Sona Nanotech Inc.?
David Andrew Regan is the chief executive officer of Sona Nanotech Inc. (SNANF).
Where is Sona Nanotech Inc. headquartered?
Sona Nanotech Inc. is headquartered in Canada.
Does SNANF pay a dividend?
Sona Nanotech Inc. (SNANF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SNANF go public?
Sona Nanotech Inc. (SNANF) completed its initial public offering in 2006.